The world’s first saliva-based PCR test provides results in under half an hour.
Authorized by Health Canada and the FDA for emergency use, Sal6830 combines the speed and convenience of an antigen test with the accuracy of a PCR test.
Find out if Sal6830 is right for your point-of-care.
Authorized for emergency use by Health Canada
Authorized for emergency use by the FDA under an EUA for use by authorized laboratories or under a CIA waiver.
Developed with the support from the National Institutes of Health (NIH), Rapid Acceleration of Diagnostics (RADx) initiative.
A Breakthrough in COVID-19 Testing
Introducing the MicroGEM Sal6830 Point-of-Care RT-qPCR Test System, the only Health Canada and FDA authorized* PCR-based Saliva Test for COVID-19 detection at the point-of-care.
Sal6830 combines easy-to-collect saliva samples with an extraction free process for ultrafast PCR results. Make quick decisions about a person’s health at the point-of-care.
sample is noninvasive,
making testing comfortable
comfortable for clients.
Results while patients wait
Results in under 30 minutes, simplifying the testing experience.
Differentiate your offerings
Distinguish your testing services
from others with the only saliva-based PCR test authorized for use in Canada.
Minimizes false positives
Point-of-care technology captures intact virus, an important
indicator of a current infection.